| Financial Year |
March 31 2023 |
| Monetary Funds |
541,530,113.77 |
| Held-for-trading Financial Assets |
88,522,090.49 |
| Notes Receivable |
16,594,865.10 |
| Accounts Receivable |
146,785,651.46 |
| Advances to Suppliers |
9,536,493.57 |
| Other Receivables |
7,443,702.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
106,267,530.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
410,568.80 |
| Total Current Assets |
972,836,246.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
92,011,925.19 |
| Investment Properties |
-- |
| Fixed Assetes |
74,167,273.32 |
| Under-construction Projects |
3,746,129.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,731,850.18 |
| R&D expenses |
-- |
| Goodwill |
26,449,405.66 |
| Long-Term Deferred and Prepaid Expenses |
981,927.43 |
| Deferred Income Tax Assets |
2,976,531.25 |
| Other Non-Current Assets |
3,836,591.60 |
| Sub-Total of Non-Current Assets |
233,584,774.01 |
| Total Assets |
1,206,421,020.83 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,192,300.00 |
| Accounts Payable |
112,424,627.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,162,393.99 |
| Taxes Payable |
8,556,088.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,073,858.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,037,985.01 |
| Other Current Liabilities |
300,258.70 |
| Sub-Total of Current Liabilities |
249,217,911.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
806,056.79 |
| Total Liabilities |
250,023,968.57 |
| Paid-In Capital(Or Share Stock) |
203,820,000.00 |
| Capital Surplus |
233,359,926.72 |
| Surplus Reserve |
61,682,857.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
443,165,280.09 |
| Minority Stockholder's Interest |
14,368,987.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
942,028,064.32 |
| Owner's Equity（Stockholder's Equity） |
956,397,052.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,206,421,020.83 |
